Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

: Devonshire V, Havrdova E, Radue EW, O´Connor P, Zhang-Aubersson L, Agoropoulou C, Häring DA, Francis G, Kappos L, Freedoms Study Group

: 2012

 Lancet Neurology

: 11

: 5

: 420

: 428

: 9

: 1474-4422

DOI: https://doi.org/10.1016/S1474-4422(12)70056-X